Peng Wang
Guangzhou University of Chinese Medicine(CN)University of Science and Technology of China(CN)Memorial Sloan Kettering Cancer Center(US)University of Kentucky(US)Hunan Normal University(CN)Yunnan University(CN)Dalian Medical University(CN)Chinese Academy of Sciences(CN)Peking University(CN)University of Macau(MO)Cornell University(US)Ningxia University(CN)Sichuan University(CN)Fudan University(CN)Hefei Institutes of Physical Science(CN)Changsha Normal University(CN)Zhengzhou University(CN)University of Chicago(US)Panyu Hospital of Chinese Medicine(CN)West China Hospital of Sichuan University(CN)Jiaxing University(CN)First Affiliated Hospital of Guangzhou Medical University(CN)Hubei University of Arts and Science(CN)Xiangyang Central Hospital(CN)Shengli Oilfield Central Hospital(CN)Panyu District Central Hospital(CN)UPMC Hillman Cancer Center(US)Northern Jiangsu People's Hospital(CN)First Affiliated Hospital of Dalian Medical University(CN)Peking University Third Hospital(CN)Henan Cancer Hospital(CN)Zhengzhou Business University(CN)Second Affiliated Hospital of Zhejiang University(CN)Tongji Hospital(CN)Baotou Medical College(CN)Union Hospital(CN)Weill Cornell Medicine(US)Huazhong University of Science and Technology(CN)Hainan Medical University(CN)Guangzhou Medical University(CN)Bohai University(CN)
Publications by Year
Research Areas
Cancer-related molecular mechanisms research, Cancer Immunotherapy and Biomarkers, Autophagy in Disease and Therapy, RNA Research and Splicing, Cancer Genomics and Diagnostics
Most-Cited Works
- → Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies(2019)1,057 cited
- → A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach(2008)849 cited
- → Peptide binding predictions for HLA DR, DP and DQ molecules(2010)697 cited
- → Transcriptional reprogramming of mature CD4+ helper T cells generates distinct MHC class II–restricted cytotoxic T lymphocytes(2013)372 cited
- → Multi-Omics Profiling Reveals Distinct Microenvironment Characterization and Suggests Immune Escape Mechanisms of Triple-Negative Breast Cancer(2019)360 cited
- → CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer(2020)204 cited